GORE CARDIOFORM ASD Occluder Adverse Events: FDA MAUDE Data

W. L. Gore & Associates, Inc. · Transcatheter Septal Occluder (ASD/PFO) · First cleared Aug 2006

Total Reports

137

Reports (30d)

0

Active Signals

0

Open Recalls

11

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Pericardial Effusion During Deployment

implanted gore, asd occluder, doing, cardioform asd, physician implanted

2

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

FDA recalls for this device

Class II

Dec 14, 2022 · Open, Classified

Septal Occluders released with incomplete quality test documentation that assesses the release of the device from the delivery system during the index procedure. A potential failure of this quality test could potentially result could result in occluder embolization, anoxic brain injury, central venous or arterial perforation or rupture.

Class II

Sep 21, 2022 · Open, Classified

Due to manufacturing records (Release Test Results) indicating "Failed".

Class II

Sep 2, 2021 · Open, Classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Class II

Sep 2, 2021 · Open, Classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Class II

Sep 2, 2021 · Open, Classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Class II

Sep 2, 2021 · Open, Classified

Septal Occluders contain the incorrect expiration date. Product is labeled with a 3 yr. expiration date instead of 2 yrs.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.